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The impact of the presence and extent of valve calcification on long-term
results of percutaneous mitral commissurotomy
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Purpose: The indication of percutaneous mitral commissurotomy (PMC) is
debated in patients (pts) with calcified mitral stenosis. We report outcome up
to 20 years according to the presence and the extent of valve calcification.
Methods: PMC was performed in 1024 consecutive pts between 1986 and
1995: 710 pts had non-calcified valves (NCAL group) and 314 had valve cal-
cification (CAL group) graded from 1 (mild) to 4 (extensive) using fluo-
roscopy. 177 pts (57%) were grade 1, 89 (28%) grade 2 and 48 (15%) grade
3 or 4.
Results: Good immediate results (GIR), defined as final valve area ≥1.5 cm²
without mitral regurgitation >2/4, were obtained in 93% in NCAL group vs.
80% in CAL group (p<0.0001). Among CAL group, GIR were 87% for grade
1 calcification vs. 72% for grades 2,3 and 4 (p=0.01).
Good functional results (GFR) were defined as survival without interven-
tion and in NYHA class I or II. 20-year rates of GFR were 38±3% for NCAL
group and 12±3% in CAL group (p<0.0001). Among pts with GIR, 20 year
rates of GFR were 40±3% in NCAL group vs. 21±3% in CAL group
(p<0.0001). In CAL group predictors of GFR after GIR were: younger age
(p=0.003), lower NYHA class (p=0.01), sinus rhythm (p=0.0002), lower post-
PMC mean gradient (p<0.0001) and a lower extent of valve calcification
(p=0.015).
According to the extent of valve calcification, 15-year rates of GFR after
GIR were 35±4% for pts in grade 1 vs. 19±4% for pts in grades 2, 3 and 4
(p=0.01).
Conclusion: This study further confirms the negative prognostic impact of
valve calcification on immediate and long-term results of PMC. PMC may,
however, be considered to defer valve surgery in selected patients. In partic-
ular, more than 1 patient out of 3 with mild calcification still benefits from
PMC 15 years after GIR. Young patients with few symptoms and in sinus
rhythm are likely to benefit from PMC, even with calcified valves.
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Left atrial remodeling after successful ballon mitral valvuloplasty
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Background: Left atrium (LA) remodeling has a crucial adverse impact on
outcome and prognosis in mitral stenosis. Few studies have reported the effect
of balloon mitral valvuloplasty (BMV) on LA volume and function. The aim
of this study was to assess the evolution of LA volume and compliance 1 and
6 months after successful BMV in patients in sinus rhythm.
Methods: 95 consecutive patients (70% women; age 31±8 years; range 19-
45) with severe mitral stenosis (mitral valve area ≤14 cm(2) ) who underwent
successful BMV were included prospectively. Using-dimensional echocardio-
graphy, and according to the prolate ellipse method, LA volume, area and
compliance (The maximum and the minimum LA volume were calculated
from apical four- and two-chamber zoomed views of the LA, using the biplane
method of discs. The difference between maximum and minimum LA volume
divided by the minimum LA volume was used as an index of atrial compli-
ance) were determined before BMV, and 1 month and 6 months after BMV.
LV global systolic function was evaluated by EF, by the biplane Simpson
method. Longitudinal left ventricular annular velocities were quantified by
spectral pulsed wave Doppler tissue velocity imaging
Results: Mitral valve area increased from 0.88±0.2 to 1.8±0.26 cm(2)
(P<0.0001). Mean mitral valve gradient (MVG) decreased from 14±6 to 6±
2 mmHg (P<0.0001) immediately after BMV. Indexed LA volume fell from
66±14 to 52±12 mL/m (2) (P=0.02) after BMV and to 45±13 mL/m (2) at
6 month (P<0.01) and an increase 0f the atrial index. Only patients with a
median LA volume ≥55 mL/m (2) before BMV had a significant reduction in
LA volume (P=0.0001). Decrease in LA volume was correlated with decreases
in PA-RV peak diastolic gradient (r=0.45, P=0.008) and MVG (r=0.35,
P=0.04). 
Conclusion: In patients with mitral stenosis in sinus rhythm, successful
BMV results in an immediate decrease in LA volume. This reduction, max-
imal immediately after BMV, correlates with decreases in MVG and PA-RV
peak diastolic gradient, and is significant only when LA volume before BMV
is severely enlarged.
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Introduction: The right ventricular function is an important determinant of
clinical symptoms, exercise capacity, pre-operative survival and post-opera-
tive outcome in patients with mitral stenosis (MS).
Objectif: The aim of this work was to evaluate the impact of percutaneous
mitral commissurotomy (PMC) on right ventricular function (RV) in patients
with severe mitral stenosis managed in Center of cardiology- University Hos-
pital IBN Rochd-Casablanca.
Methods and results: Of 150 patients there were 20 men and 130 women,
their mean age was 35±10 years. One hundred were in New York Heart Asso-
ciation class II, 40 in class III and 10 in class IV. Eighty patients with atrial
fibrillation.
Were studied before and after PMC. Multiple parameters of global and lon-
gitudinal RV function were assessed by conventional and tissue Doppler
imaging echocardiography
Mitral surface area and hemodynamic parameters improved significantly after
PMC; mean left atrial pressure fell from 18.76±6.18 to 10.65±4.38 mmHg
(P<0.001), mean transmitral gradient from 14.03±4.70 to 4.63±2.05mmHg
(p<0.001) and mitral valve area from 0.99±0.22 to 1.88±0.41 cm2 (p<0.001), in
the RV Tei index from 0.44+0.025 to 0.29+0.17 (P 1/4 0.021), in myocardial
acceleration during isovolumic contraction (IVA) at the lateral tricuspid annulus
from 0.36+0.11 m/s2 to 0.25+0.07 m/s2 (P 1/4 0.023), and in isovolumic
contraction velocities at the lateral tricuspid annulus from 11.03+3.37 cm/s to
8.50+2.04 cm/s (P 1/4 0.034).
Conclusion: This study demonstrates that, in patients with MS, global
right ventricular function improves in the majority of patients.
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Background: Benfluorex was withdrawn from European markets in June
2010 following reports of an association with heart valve lesions. The link
